Printer Friendly

Eksigent Technologies Launches NanoLC-2D Proteomics System.

Business Editors/Health/Medical Writers


LIVERMORE, Calif.--(BUSINESS WIRE)--Jan. 22, 2004

Eksigent's Direct Pumping Nanoscale

HPLC System is Now Available with the Added

Convenience of Automated 2-Dimensional Separations

Eksigent Technologies, a leader in the field of microfluidics, today announced the introduction of its NanoLC-2D Proteomics System. The NanoLC-2D System is the first HPLC (High Performance Liquid Chromatography) system to incorporate fully automated 2-dimensional HPLC separations with a direct pumping nanoscale HPLC system. The system provides significant enhancements in detection sensitivity and reproducibility for LC/MS proteomics studies, with the added convenience of automatically running 2-dimensional peptide separations, such as the frequently cited MudPIT method. The newly launched NanoLC-2D Proteomics system incorporates Eksigent's Microfluidic Flow Control (MFC) technology, which uses continuous feedback to an electronically controlled pressure source to maintain precise nanoscale flow rates without flow splitting. Instrument Business Outlook recently recognized the 1-dimensional version of the system, which was launched in 2003, as one of the leading systems for nanoscale chromatography.

The NanoLC-2D system will include a complete line of instruments and consumables. The system includes two binary gradient pump systems, autosampler, first and second dimension injection valves, control software, and separation columns. Dr. Karen Hahnenberger, NanoLC Product Manager, stated, "We are very excited to be launching the NanoLC-2D System. The system is extremely flexible; it can operate in automatic 2D mode, the first channel can be used for rapid sample loading, or both channels can run simultaneously as two completely independent binary gradient systems. In automatic 2D mode, the first dimension separation -- typically strong cation exchange -- can be run as a step gradient or as a linear gradient. Furthermore, the NanoLC-2D system will include full integration with Thermo Electron's Xcalibur(R) mass spectrometer software control."

According to David Neyer, Ph.D., Technology Development Manager, "2-dimensional HPLC separations provide a significant increase in separation capacity versus 1-dimensional separations. The NanoLC-2D system combines automated 2-dimensional capability with the NanoLC system's precise nanoscale gradients, simple system operation, elimination of flow splitting, and automatic peak parking capability. This unique set of features makes the NanoLC-2D system ideally suited for multidimensional peptide analysis."

About Eksigent Technologies

Eksigent Technologies is pioneering microfluidic systems for use in proteomics, drug discovery, medical devices, and other life science applications. Eksigent's core microfluidic technologies include microscale pumping, micro-optics, and microfabrication. Products include the NanoLC system for highly sensitive LC/MS, the Express system for high throughput analytical HPLC, and the EKPump for drug delivery. More information about the company is available at
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jan 22, 2004
Previous Article:PFSweb Helps Make United States Mint Tops in Customer Satisfaction; American Customer Satisfaction Index Gives Mint Highest Score Ever Attained by a...
Next Article:Itron Announces Q4 & Y/E 2003 Earnings Release Conference Call Details.

Related Articles
Eksigent Technologies Launches NanoLC Proteomics System; System Increases Detection Sensitivity in LC/MS/MS Protein Identification.
The Human Proteome Organization (HUPO) and Environmental Health. (Commentary).
Proteomics: characterizing the cogs in the machinery of life.
Eksigent Technologies Expands Commercial Operations.
Biomedical Applications of Proteomics.
Advances in Protein Chemistry, Volume 65: Proteome Characterization and Proteomics.
Oxford University Press acquires two journals; launch in 2006.

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters